Clinical Research Papers:

Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma

Ying Li, Junru Liu, Beihui Huang, Meilan Chen, Xiangwen Diao and Juan Li _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:25637-25649. https://doi.org/10.18632/oncotarget.11418

Metrics: PDF 2145 views  |   HTML 2127 views  |   ?  


Ying Li1, Junru Liu1, Beihui Huang1, Meilan Chen1, Xiangwen Diao1 and Juan Li1

1 Department of Hematology of The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Correspondence to:

Juan Li, email:

Keywords: multiple myeloma, PET/CT, treatment response

Received: February 02, 2016 Accepted: August 13, 2016 Published: August 19, 2016


Multiple myeloma (MM) causes osteolytic lesions which can be detected by 18F-fluorodeoxyglucose positron emission tomography/Computed tomography (18F-FDG PET/CT). We prospectively involve 96 Newly diagnosed MM to take PET/CT scan at scheduled treatment time (figure 1), and 18F-FDG uptake of lesion was measured by SUVmax and T/Mmax. All MM patients took bortezomib based chemotherapy as induction and received ASCT and maintenance. All clinical features were analyzed with the PET/CT image changes, and some relationships between treatment response and FDG uptakes changes were found: Osteolytic lesions of MM uptakes higher FDG than healthy volunteers, and this trend is more obvious in extramedullary lesions. Compared to X-ray, PET/CT was more sensitive both in discoering bone as well as extramedullary lesions. In newly diagnosed MM, several adverse clinical factors were related to high FDG uptakes of bone lesions. Bone lesion FDG uptakes of MM with P53 mutation or with hypodiploidy and complex karyotype were also higher than those without such changes. In treatment response, PET/CT showed higher sensitivity in detecting tumor residual disease than immunofixation electrophoresis. But in relapse prediction, it might show false positive disease recurrences and the imaging changes might be influenced by infections and hemoglobulin levels. Conclusion: PET/CT is sensitive in discovering meduallary and extrameduallary lesions of MM, and the 18F-FDG uptake of lesions are related with clinical indictors and biological features of plasma cells. In evaluating treatment response and survival, PET/CT showed its superiority. But in predicting relapse or refractory, it may show false positive results.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11418